Problem
A. How does this genetic variant affect the efficacy and/or toxicity of a drug or drugs?
B. Do you see such an effect in specific patient populations?
C. Describe the clinical relevance of the genetic variant and affected drug therapy.
D. When considering drug therapy with the affected drug(s), is genetic testing for this association available, required, or covered by payors?
E. What else did you learn about this genetic variant that you found interesting?